Roth J - Search Results

1

Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing.

Zech M, Jech R, Wagner M, Mantel T, Boesch S, Nocker M, Jochim A, Berutti R, Havránková P, Fečíková A, Kemlink D, Roth J, Strom TM, Poewe W, Růžička E, Haslinger B, Winkelmann J. Zech M, et al. Among authors: roth j. Neurogenetics. 2017 Dec;18(4):195-205. doi: 10.1007/s10048-017-0521-9. Epub 2017 Aug 28. Neurogenetics. 2017. PMID: 28849312

2

Apomorphine induced cognitive changes in Parkinson's disease.

Růzicka E, Roth J, Spacková N, Mecír P, Jech R. Růzicka E, et al. Among authors: roth j. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):998-1001. doi: 10.1136/jnnp.57.8.998. J Neurol Neurosurg Psychiatry. 1994. PMID: 8057129 Free PMC article. Clinical Trial.

3

Apomorphine does not influence olfactory thresholds in Parkinson's disease.

Roth J, Radil T, Růzicka E, Jech R, Tichý J. Roth J, et al. Funct Neurol. 1998 Apr-Jun;13(2):99-103. Funct Neurol. 1998. PMID: 9626594

4

Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.

Roth J, Zidovská J, Růzicková S, Havrdová E, Preiss M, Uhrová T, Línek V, Doubek P, Volfová M, Jech R, Bauer J, Růzicka E. Roth J, et al. Sb Lek. 1999;100(1):39-44. Sb Lek. 1999. PMID: 10860124

5

Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.

Růzicka E, Roth J, Jech R, Busek P. Růzicka E, et al. Among authors: roth j. Mov Disord. 2000 Jul;15(4):734-5. doi: 10.1002/1531-8257(200007)15:4<734::aid-mds1022>3.0.co;2-e. Mov Disord. 2000. PMID: 10928588 No abstract available.

6

Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease.

Růzicka E, Streitová H, Jech R, Kanovský P, Roth J, Rektorová I, Mecír P, Hortová H, Bares M, Hejduková B, Rektor I. Růzicka E, et al. Among authors: roth j. J Neural Transm (Vienna). 2000;107(11):1297-306. doi: 10.1007/s007020070019. J Neural Transm (Vienna). 2000. PMID: 11145005 Clinical Trial.

7

Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson's disease.

Jech R, Urgosík D, Tintera J, Nebuzelský A, Krásenský J, Liscák R, Roth J, Růzicka E. Jech R, et al. Among authors: roth j. Mov Disord. 2001 Nov;16(6):1126-32. doi: 10.1002/mds.1217. Mov Disord. 2001. PMID: 11748747

8

Colour discrimination impairment is not a reliable early marker of Parkinson's disease.

Veselá O, Růzicka E, Jech R, Roth J, Stepánková K, Mecír P, Solano Z, Preclíková E. Veselá O, et al. Among authors: roth j. J Neurol. 2001 Nov;248(11):975-8. doi: 10.1007/s004150170051. J Neurol. 2001. PMID: 11757962

9

Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.

Wissel J, Kanovsky P, Ruzicka E, Bares M, Hortova H, Streitova H, Jech R, Roth J, Brenneis C, Müller J, Schnider P, Auff E, Richardson A, Poewe W. Wissel J, et al. Among authors: roth j. J Neurol. 2001 Dec;248(12):1073-8. doi: 10.1007/s004150170028. J Neurol. 2001. PMID: 12013585 Clinical Trial.

10

VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy.

Růzicka E, Jech R, Zárubová K, Roth J, Urgosík D. Růzicka E, et al. Among authors: roth j. Mov Disord. 2003 Oct;18(10):1192-5. doi: 10.1002/mds.10510. Mov Disord. 2003. PMID: 14534927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,905 results

Search Page

Filters